Association of SAPAP3 Allelic Variants With Symptom Dimensions and Pharmacological Treatment Response in Obsessive-Compulsive Disorder

Though several SAPAP3 gene knockout studies in mice have implicated its role in compulsivity, human studies have failed to demonstrate its association with obsessive-compulsive disorder (OCD). We examined the association between allelic variants of a single nucleotide polymorphism in the SAPAP3 gene...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental and clinical psychopharmacology 2022-02, Vol.30 (1), p.106-112
Hauptverfasser: Naaz, Safoora, Balachander, Srinivas, Srinivasa Murthy, Nithyananda, MS, Bhagyalakshmi, Sud, Reeteka, Saha, Priyanka, Narayanaswamy, Janardhanan C., Reddy YC, Janardhan, Jain, Sanjeev, Purushottam, Meera, Viswanath, Biju
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 112
container_issue 1
container_start_page 106
container_title Experimental and clinical psychopharmacology
container_volume 30
creator Naaz, Safoora
Balachander, Srinivas
Srinivasa Murthy, Nithyananda
MS, Bhagyalakshmi
Sud, Reeteka
Saha, Priyanka
Narayanaswamy, Janardhanan C.
Reddy YC, Janardhan
Jain, Sanjeev
Purushottam, Meera
Viswanath, Biju
description Though several SAPAP3 gene knockout studies in mice have implicated its role in compulsivity, human studies have failed to demonstrate its association with obsessive-compulsive disorder (OCD). We examined the association between allelic variants of a single nucleotide polymorphism in the SAPAP3 gene (rs6662980) with specific aspects of the OCD phenotype. A total of 200 individuals with OCD were genotyped using the TaqMan assay. All participants were assessed using the Mini International Neuropsychiatric Interview and the Yale-Brown Obsessive-Compulsive Scale, and their response to serotonin reuptake inhibitors (SRIs) was evaluated over naturalistic treatment and follow-up. After correcting for multiple comparisons, the G allele at rs6662980 was found to be associated with contamination and washing symptoms (p = .003). Logistic regression analysis also showed that presence of the G allele predicted poor response to SRIs (odds ratio [OR] = 2.473, 95% confidence interval [1.157, 5.407], p = .021). Interaction between presence of the G allele and the Contamination and Washing factor score predicted greater SRI resistance (OR = 3.654, [2.761, 4.547], p = .004). We conclude that specific phenotypic manifestations of OCD, which include contamination and washing-related symptoms along with resistance to SRIs, may be affected by variations in the SAPAP3 gene. Limitations of the study are the lack of a dimensional measure for assessing OCD symptoms, the evaluation of treatment response over naturalistic follow-up, and that only a single locus in the SAPAP3 gene was examined. Public Health Significance This study finds that a polymorphism in the SAPAP3 gene is associated with the contamination and washing symptoms of obsessive-compulsive disorder and also predicts resistance to pharmacological treatment.
doi_str_mv 10.1037/pha0000422
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2429770850</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2429770850</sourcerecordid><originalsourceid>FETCH-LOGICAL-a387t-e396c6c49fad621a8d0b03ac3cf584ac4063b70120d9714b72ef001e59c3977f3</originalsourceid><addsrcrecordid>eNpdkU2LFDEQhoMo7rp68QdIwIsorfnoSTrHZvyEhR3cVY9NdTrtZEl32lRamD_g7zbDrArmUnV46iFVLyFPOXvNmdRvlj2w8moh7pFzbqSqhDDyfumZqisujD4jjxBvGeO1NOIhOZNCS8Y25pz8ahGj9ZB9nGkc6XW7a3eStiG44C39CsnDnJF-83lPrw_TkuNE3_rJzVgmkMI80N0e0gQ2hvjdWwj0JjnIhcj0s8OlUI76mV716BD9T1dt47Ss4dgWE8Y0uPSYPBghoHtyVy_Il_fvbrYfq8urD5-27WUFstG5ctIoq2xtRhiU4NAMrGcSrLTjpqnB1kzJXjMu2GA0r3st3Fi2dhtjpdF6lBfkxcm7pPhjdZi7yaN1IcDs4oqdqMu1NGs2rKDP_0Nv45rm8rsj1SimlOKFenmibIqIyY3dkvwE6dBx1h3T6f6lU-Bnd8q1n9zwF_0TRwFenQBYoFvwYCFlb4NDu6ZUDnqUdbKIi1rJ31QJmn8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2428606661</pqid></control><display><type>article</type><title>Association of SAPAP3 Allelic Variants With Symptom Dimensions and Pharmacological Treatment Response in Obsessive-Compulsive Disorder</title><source>MEDLINE</source><source>EBSCOhost APA PsycARTICLES</source><creator>Naaz, Safoora ; Balachander, Srinivas ; Srinivasa Murthy, Nithyananda ; MS, Bhagyalakshmi ; Sud, Reeteka ; Saha, Priyanka ; Narayanaswamy, Janardhanan C. ; Reddy YC, Janardhan ; Jain, Sanjeev ; Purushottam, Meera ; Viswanath, Biju</creator><contributor>Stoops, William W</contributor><creatorcontrib>Naaz, Safoora ; Balachander, Srinivas ; Srinivasa Murthy, Nithyananda ; MS, Bhagyalakshmi ; Sud, Reeteka ; Saha, Priyanka ; Narayanaswamy, Janardhanan C. ; Reddy YC, Janardhan ; Jain, Sanjeev ; Purushottam, Meera ; Viswanath, Biju ; Stoops, William W</creatorcontrib><description>Though several SAPAP3 gene knockout studies in mice have implicated its role in compulsivity, human studies have failed to demonstrate its association with obsessive-compulsive disorder (OCD). We examined the association between allelic variants of a single nucleotide polymorphism in the SAPAP3 gene (rs6662980) with specific aspects of the OCD phenotype. A total of 200 individuals with OCD were genotyped using the TaqMan assay. All participants were assessed using the Mini International Neuropsychiatric Interview and the Yale-Brown Obsessive-Compulsive Scale, and their response to serotonin reuptake inhibitors (SRIs) was evaluated over naturalistic treatment and follow-up. After correcting for multiple comparisons, the G allele at rs6662980 was found to be associated with contamination and washing symptoms (p = .003). Logistic regression analysis also showed that presence of the G allele predicted poor response to SRIs (odds ratio [OR] = 2.473, 95% confidence interval [1.157, 5.407], p = .021). Interaction between presence of the G allele and the Contamination and Washing factor score predicted greater SRI resistance (OR = 3.654, [2.761, 4.547], p = .004). We conclude that specific phenotypic manifestations of OCD, which include contamination and washing-related symptoms along with resistance to SRIs, may be affected by variations in the SAPAP3 gene. Limitations of the study are the lack of a dimensional measure for assessing OCD symptoms, the evaluation of treatment response over naturalistic follow-up, and that only a single locus in the SAPAP3 gene was examined. Public Health Significance This study finds that a polymorphism in the SAPAP3 gene is associated with the contamination and washing symptoms of obsessive-compulsive disorder and also predicts resistance to pharmacological treatment.</description><identifier>ISSN: 1064-1297</identifier><identifier>EISSN: 1936-2293</identifier><identifier>DOI: 10.1037/pha0000422</identifier><identifier>PMID: 32730059</identifier><language>eng</language><publisher>United States: American Psychological Association</publisher><subject>Alleles ; Animals ; Drug Therapy ; Female ; Genes ; Genotype ; Human ; Male ; Mice ; Nerve Tissue Proteins - genetics ; Nucleotides ; Obsessive Compulsive Disorder ; Obsessive-Compulsive Disorder - drug therapy ; Obsessive-Compulsive Disorder - genetics ; Phenotypes ; Polymorphism ; Psychiatric Status Rating Scales ; Serotonin Reuptake Inhibitors ; Serotonin Uptake Inhibitors ; Treatment Resistant Disorders</subject><ispartof>Experimental and clinical psychopharmacology, 2022-02, Vol.30 (1), p.106-112</ispartof><rights>2020 American Psychological Association</rights><rights>2020, American Psychological Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a387t-e396c6c49fad621a8d0b03ac3cf584ac4063b70120d9714b72ef001e59c3977f3</citedby><orcidid>0000-0002-7317-1789 ; 0000-0001-6729-6414 ; 0000-0002-4000-268X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32730059$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Stoops, William W</contributor><creatorcontrib>Naaz, Safoora</creatorcontrib><creatorcontrib>Balachander, Srinivas</creatorcontrib><creatorcontrib>Srinivasa Murthy, Nithyananda</creatorcontrib><creatorcontrib>MS, Bhagyalakshmi</creatorcontrib><creatorcontrib>Sud, Reeteka</creatorcontrib><creatorcontrib>Saha, Priyanka</creatorcontrib><creatorcontrib>Narayanaswamy, Janardhanan C.</creatorcontrib><creatorcontrib>Reddy YC, Janardhan</creatorcontrib><creatorcontrib>Jain, Sanjeev</creatorcontrib><creatorcontrib>Purushottam, Meera</creatorcontrib><creatorcontrib>Viswanath, Biju</creatorcontrib><title>Association of SAPAP3 Allelic Variants With Symptom Dimensions and Pharmacological Treatment Response in Obsessive-Compulsive Disorder</title><title>Experimental and clinical psychopharmacology</title><addtitle>Exp Clin Psychopharmacol</addtitle><description>Though several SAPAP3 gene knockout studies in mice have implicated its role in compulsivity, human studies have failed to demonstrate its association with obsessive-compulsive disorder (OCD). We examined the association between allelic variants of a single nucleotide polymorphism in the SAPAP3 gene (rs6662980) with specific aspects of the OCD phenotype. A total of 200 individuals with OCD were genotyped using the TaqMan assay. All participants were assessed using the Mini International Neuropsychiatric Interview and the Yale-Brown Obsessive-Compulsive Scale, and their response to serotonin reuptake inhibitors (SRIs) was evaluated over naturalistic treatment and follow-up. After correcting for multiple comparisons, the G allele at rs6662980 was found to be associated with contamination and washing symptoms (p = .003). Logistic regression analysis also showed that presence of the G allele predicted poor response to SRIs (odds ratio [OR] = 2.473, 95% confidence interval [1.157, 5.407], p = .021). Interaction between presence of the G allele and the Contamination and Washing factor score predicted greater SRI resistance (OR = 3.654, [2.761, 4.547], p = .004). We conclude that specific phenotypic manifestations of OCD, which include contamination and washing-related symptoms along with resistance to SRIs, may be affected by variations in the SAPAP3 gene. Limitations of the study are the lack of a dimensional measure for assessing OCD symptoms, the evaluation of treatment response over naturalistic follow-up, and that only a single locus in the SAPAP3 gene was examined. Public Health Significance This study finds that a polymorphism in the SAPAP3 gene is associated with the contamination and washing symptoms of obsessive-compulsive disorder and also predicts resistance to pharmacological treatment.</description><subject>Alleles</subject><subject>Animals</subject><subject>Drug Therapy</subject><subject>Female</subject><subject>Genes</subject><subject>Genotype</subject><subject>Human</subject><subject>Male</subject><subject>Mice</subject><subject>Nerve Tissue Proteins - genetics</subject><subject>Nucleotides</subject><subject>Obsessive Compulsive Disorder</subject><subject>Obsessive-Compulsive Disorder - drug therapy</subject><subject>Obsessive-Compulsive Disorder - genetics</subject><subject>Phenotypes</subject><subject>Polymorphism</subject><subject>Psychiatric Status Rating Scales</subject><subject>Serotonin Reuptake Inhibitors</subject><subject>Serotonin Uptake Inhibitors</subject><subject>Treatment Resistant Disorders</subject><issn>1064-1297</issn><issn>1936-2293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU2LFDEQhoMo7rp68QdIwIsorfnoSTrHZvyEhR3cVY9NdTrtZEl32lRamD_g7zbDrArmUnV46iFVLyFPOXvNmdRvlj2w8moh7pFzbqSqhDDyfumZqisujD4jjxBvGeO1NOIhOZNCS8Y25pz8ahGj9ZB9nGkc6XW7a3eStiG44C39CsnDnJF-83lPrw_TkuNE3_rJzVgmkMI80N0e0gQ2hvjdWwj0JjnIhcj0s8OlUI76mV716BD9T1dt47Ss4dgWE8Y0uPSYPBghoHtyVy_Il_fvbrYfq8urD5-27WUFstG5ctIoq2xtRhiU4NAMrGcSrLTjpqnB1kzJXjMu2GA0r3st3Fi2dhtjpdF6lBfkxcm7pPhjdZi7yaN1IcDs4oqdqMu1NGs2rKDP_0Nv45rm8rsj1SimlOKFenmibIqIyY3dkvwE6dBx1h3T6f6lU-Bnd8q1n9zwF_0TRwFenQBYoFvwYCFlb4NDu6ZUDnqUdbKIi1rJ31QJmn8</recordid><startdate>20220201</startdate><enddate>20220201</enddate><creator>Naaz, Safoora</creator><creator>Balachander, Srinivas</creator><creator>Srinivasa Murthy, Nithyananda</creator><creator>MS, Bhagyalakshmi</creator><creator>Sud, Reeteka</creator><creator>Saha, Priyanka</creator><creator>Narayanaswamy, Janardhanan C.</creator><creator>Reddy YC, Janardhan</creator><creator>Jain, Sanjeev</creator><creator>Purushottam, Meera</creator><creator>Viswanath, Biju</creator><general>American Psychological Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7RZ</scope><scope>PSYQQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7317-1789</orcidid><orcidid>https://orcid.org/0000-0001-6729-6414</orcidid><orcidid>https://orcid.org/0000-0002-4000-268X</orcidid></search><sort><creationdate>20220201</creationdate><title>Association of SAPAP3 Allelic Variants With Symptom Dimensions and Pharmacological Treatment Response in Obsessive-Compulsive Disorder</title><author>Naaz, Safoora ; Balachander, Srinivas ; Srinivasa Murthy, Nithyananda ; MS, Bhagyalakshmi ; Sud, Reeteka ; Saha, Priyanka ; Narayanaswamy, Janardhanan C. ; Reddy YC, Janardhan ; Jain, Sanjeev ; Purushottam, Meera ; Viswanath, Biju</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a387t-e396c6c49fad621a8d0b03ac3cf584ac4063b70120d9714b72ef001e59c3977f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Alleles</topic><topic>Animals</topic><topic>Drug Therapy</topic><topic>Female</topic><topic>Genes</topic><topic>Genotype</topic><topic>Human</topic><topic>Male</topic><topic>Mice</topic><topic>Nerve Tissue Proteins - genetics</topic><topic>Nucleotides</topic><topic>Obsessive Compulsive Disorder</topic><topic>Obsessive-Compulsive Disorder - drug therapy</topic><topic>Obsessive-Compulsive Disorder - genetics</topic><topic>Phenotypes</topic><topic>Polymorphism</topic><topic>Psychiatric Status Rating Scales</topic><topic>Serotonin Reuptake Inhibitors</topic><topic>Serotonin Uptake Inhibitors</topic><topic>Treatment Resistant Disorders</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Naaz, Safoora</creatorcontrib><creatorcontrib>Balachander, Srinivas</creatorcontrib><creatorcontrib>Srinivasa Murthy, Nithyananda</creatorcontrib><creatorcontrib>MS, Bhagyalakshmi</creatorcontrib><creatorcontrib>Sud, Reeteka</creatorcontrib><creatorcontrib>Saha, Priyanka</creatorcontrib><creatorcontrib>Narayanaswamy, Janardhanan C.</creatorcontrib><creatorcontrib>Reddy YC, Janardhan</creatorcontrib><creatorcontrib>Jain, Sanjeev</creatorcontrib><creatorcontrib>Purushottam, Meera</creatorcontrib><creatorcontrib>Viswanath, Biju</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>APA PsycArticles®</collection><collection>ProQuest One Psychology</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental and clinical psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Naaz, Safoora</au><au>Balachander, Srinivas</au><au>Srinivasa Murthy, Nithyananda</au><au>MS, Bhagyalakshmi</au><au>Sud, Reeteka</au><au>Saha, Priyanka</au><au>Narayanaswamy, Janardhanan C.</au><au>Reddy YC, Janardhan</au><au>Jain, Sanjeev</au><au>Purushottam, Meera</au><au>Viswanath, Biju</au><au>Stoops, William W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of SAPAP3 Allelic Variants With Symptom Dimensions and Pharmacological Treatment Response in Obsessive-Compulsive Disorder</atitle><jtitle>Experimental and clinical psychopharmacology</jtitle><addtitle>Exp Clin Psychopharmacol</addtitle><date>2022-02-01</date><risdate>2022</risdate><volume>30</volume><issue>1</issue><spage>106</spage><epage>112</epage><pages>106-112</pages><issn>1064-1297</issn><eissn>1936-2293</eissn><abstract>Though several SAPAP3 gene knockout studies in mice have implicated its role in compulsivity, human studies have failed to demonstrate its association with obsessive-compulsive disorder (OCD). We examined the association between allelic variants of a single nucleotide polymorphism in the SAPAP3 gene (rs6662980) with specific aspects of the OCD phenotype. A total of 200 individuals with OCD were genotyped using the TaqMan assay. All participants were assessed using the Mini International Neuropsychiatric Interview and the Yale-Brown Obsessive-Compulsive Scale, and their response to serotonin reuptake inhibitors (SRIs) was evaluated over naturalistic treatment and follow-up. After correcting for multiple comparisons, the G allele at rs6662980 was found to be associated with contamination and washing symptoms (p = .003). Logistic regression analysis also showed that presence of the G allele predicted poor response to SRIs (odds ratio [OR] = 2.473, 95% confidence interval [1.157, 5.407], p = .021). Interaction between presence of the G allele and the Contamination and Washing factor score predicted greater SRI resistance (OR = 3.654, [2.761, 4.547], p = .004). We conclude that specific phenotypic manifestations of OCD, which include contamination and washing-related symptoms along with resistance to SRIs, may be affected by variations in the SAPAP3 gene. Limitations of the study are the lack of a dimensional measure for assessing OCD symptoms, the evaluation of treatment response over naturalistic follow-up, and that only a single locus in the SAPAP3 gene was examined. Public Health Significance This study finds that a polymorphism in the SAPAP3 gene is associated with the contamination and washing symptoms of obsessive-compulsive disorder and also predicts resistance to pharmacological treatment.</abstract><cop>United States</cop><pub>American Psychological Association</pub><pmid>32730059</pmid><doi>10.1037/pha0000422</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-7317-1789</orcidid><orcidid>https://orcid.org/0000-0001-6729-6414</orcidid><orcidid>https://orcid.org/0000-0002-4000-268X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1064-1297
ispartof Experimental and clinical psychopharmacology, 2022-02, Vol.30 (1), p.106-112
issn 1064-1297
1936-2293
language eng
recordid cdi_proquest_miscellaneous_2429770850
source MEDLINE; EBSCOhost APA PsycARTICLES
subjects Alleles
Animals
Drug Therapy
Female
Genes
Genotype
Human
Male
Mice
Nerve Tissue Proteins - genetics
Nucleotides
Obsessive Compulsive Disorder
Obsessive-Compulsive Disorder - drug therapy
Obsessive-Compulsive Disorder - genetics
Phenotypes
Polymorphism
Psychiatric Status Rating Scales
Serotonin Reuptake Inhibitors
Serotonin Uptake Inhibitors
Treatment Resistant Disorders
title Association of SAPAP3 Allelic Variants With Symptom Dimensions and Pharmacological Treatment Response in Obsessive-Compulsive Disorder
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T15%3A46%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20SAPAP3%20Allelic%20Variants%20With%20Symptom%20Dimensions%20and%20Pharmacological%20Treatment%20Response%20in%20Obsessive-Compulsive%20Disorder&rft.jtitle=Experimental%20and%20clinical%20psychopharmacology&rft.au=Naaz,%20Safoora&rft.date=2022-02-01&rft.volume=30&rft.issue=1&rft.spage=106&rft.epage=112&rft.pages=106-112&rft.issn=1064-1297&rft.eissn=1936-2293&rft_id=info:doi/10.1037/pha0000422&rft_dat=%3Cproquest_cross%3E2429770850%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2428606661&rft_id=info:pmid/32730059&rfr_iscdi=true